Enrich Therapeutics Inc.

Enrich develops a groundbreaking single-cell isolation technology to enable validated clone isolation under desired microenvironment with real-time monitoring.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Branford, CT, USA
  • Currency USD
  • Founded July 2018
  • Employees 6
  • Incorporation Type C-corp
  • Website enrichtx.com

Company Summary

Enrich develops a groundbreaking cell isolation technology that allows scientists to not only observe cell-cell interactions, but also isolate the meaningful clones with desired features. Our technology uses scalable inexpensive, but highly precise, liquid crystal display (LCD) light to catalyze a reversible chemical reaction that allows capturing and protecting individual cells or cell combinations which meet user-defined criteria.

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free